"The shifts in the financial markets, international forces and the 2008 election will have enormous impact on the future of new technology in healthcare. The Medical Innovation Summit provides unrivaled insights, exceptional networking and actionable takeaways for anyone who cares about medical innovation."
- Tim Ring, CR Bard
CEOS of GE, Johnson & Johnson, Eli Lilly, Abbott, AstraZeneca, Amgen, Boston
Scientific, 3M, Medtronic and Edwards Lifesciences; partners from top venture
firms, heads of Government agencies and top clinicians.
IN MEMORIAM
Andrew C. Novick, MD
1948 - 2008
|
| Cleveland, Ohio | InterContinental Hotel & Bank of America Conference Center |
Past Summits
2003 LIST OF SPEAKERS:
- Pamela G. Bailey, President,
AdvaMed
- John W. Brown, Chairman &
CEO, Stryker Corporation
- Jane Campbell, Mayor, City
of Cleveland
- Samuel D. Colella, Co-Founder
& Managing Director, Versant Ventures
- Arthur D. Collins Jr., Chairman
& CEO, Medtronic
- Francis S. Collins, Director,
National Human Genome Research Institute
- Delos M. Cosgrove MD, CCF
- Brian H. Dovey, General Partner,
Domain Associates
- Thomas J. Fogerty MD, Co-Founder
& Senior Partner, Three Arch Partners
- Joseph F. Hahn, Chairman, CCF;
Chairman/Division of Surgery, CCF
- C. Martin Harris MD, Chief
Information Officer, CCF
- George N. Hatsopoulos PhD,
Chairman & Founder, Pharos; Founder & CEO Emeritus,
Thermo Electron
- Jouko Karvinen, President &
CEO, Philips Medical Systems
- Keith M. Kerman MD, Managing
Director, Primus Venture Partners
- Carl F. Kohrt PhD, President
& CEO, Battelle
- Caroline A. Kovac PhD, General
Manager, IBM Life Sciences
- Harry M Kraemer Jr., Chairman
& CEO, Baxter
- Jack W. Lasersohn, General
Partner, The Vertical Group
- Floyd D. Loop MD, Chairman
& CEO, CCF
- Edward J. Ludwig, Chairman,
President & CEO, BD
- Richard L. Marrapese, Partner,
Ernst & Young Healthcare and Life Sciences Practices
- Mark B. McClellan MD, PhD,
Commissioner, U.S. Food and Drug Administration
- Dane A. Miller PhD, President
& CEO, Biomet
- A. Malachi Mixon III, Chairman
& CEO, Invacare
- Scott W. Morrison, Partner,
Ernst & Young Healthcare and Life Sciences Practices
- Michael A. Mussallem, Chairman
& CEO, Edwards Lifesciences
- Harry T. Rein, Senior Advisor,
Foundation Medical Partners
- Erich R. Reinhardt D. Eng,
President & CEO, Siemens Medical Solutions
- Timothy M. Ring, Chairman &
CEO, C.R. Bard
- Bill R. Sanford, Executive
Founder & Retired Chairman and CEO, STERIS; Chairman, BioEnterprise
- Thomas A. Scully, Administrator,
Centers for Medicare & Medicaid Services
- Bob Taft, Governor, State of
Ohio
- Eric J. Topol MD, Provost &
Chief Academic Officer, CC
- Les C. Vinney, President &
CEO, STERIS
- John P. Wareham, Chairman,
President & CEO, Beckman Coulter
- Raymond P. Warrell Jr. MD,
Chairman & CEO, Genta
- William C. Weldon, Chairman
& CEO, Johnson & Johnson
- Miles D. White, Chairman &
CEO, Abbott Laboratories
- Ron Winslow, Health Editor,
Wall Street Journal
2003 AGENDA:
Monday, October 6, 2003
| 6:00 - 9:00 P.M. |
Early Registration |
Tuesday, October 7, 2003
| 7:00 – 8:00 A.M. |
Registration and Continental Breakfast |
| 8:00 – 8:45 A.M. |
Welcome to The Cleveland Clinic Foundation and
the City of Cleveland
A. Malachi Mixon III
Chairman and CEO, Invacare;
Chairman of the Board of Trustees, The Cleveland Clinic
Foundation
Floyd D. Loop, M.D.
Chairman and CEO, The Cleveland Clinic Foundation
The Honorable Jane L. Campbell, Mayor
City of Cleveland, Ohio |
| 8:45 – 9:45 A.M. |
The Human Genome:
From Discovery to Therapies
Francis S. Collins, M.D., Ph.D.
Director, National Human Genome Research Institute
Introduction by Delos M. Cosgrove, M.D.
Chairman, Department of Thoracic & Cardiovascular Surgery
The Cleveland Clinic Foundation |
| 9:45 – 10:05 A.M. |
Break |
| 10:05 – 11:30 A.M. |
Innovation and Integration:
Scientific and Technological Advances Redefining Medicine
Richard L. Marrapese and Scott W. Morrison
Partners, Ernst and Young Healthcare and Life Sciences Practices
Introduction by Michael P. O’Boyle
Chief Financial Officer, The Cleveland Clinic Foundation |
| 11:30 – 12:50 P.M. |
Luncheon
The Honorable Bob Taft
Governor of Ohio
Making Medical Innovation Available:
Patient Access to New Technology
Arthur D. Collins, Jr.
Chairman and CEO, Medtronic
Introduction by Joseph F. Hahn, M.D.
Chairman, Division of Surgery, The Cleveland Clinic Foundation |
| 1:00 – 2:00 P.M. |
The Need for Speed:
Bench to Boardroom to Bedside
Mark B. McClellan, M.D., Ph.D.
Commissioner of the U.S. Food and Drug Administration
Introduction by Eric J. Topol, M.D.
Provost and Chief Academic Officer, The Cleveland Clinic
Foundation |
| 2:00 – 2:15 P.M. |
Break |
| 2:15 – 3:45 P.M. |
Ensuring Availability to All Who Need It:
What Can Industry Leaders Do?
Moderator:
Pamela G. Bailey
President, AdvaMed
Panel:
Dane A. Miller, Ph.D.
President and CEO, Biomet
Michael A. Mussallem
Chairman and CEO, Edwards Lifesciences
Timothy M. Ring
Chairman and CEO, C.R. Bard |
| 3:45 – 4:35 P.M. |
Financial Relationships Among Industry, Scientific
Investigators,
And Academic Institutions
John P. Wareham
Chairman, President and CEO, Beckman Coulter
Introduction by Robert Kay, M.D.
Vice Chairman, Board of Governors, The Cleveland Clinic
Foundation |
| 4:35 – 5:00 P.M. |
Break |
| 5:00 – 6:00 P.M. |
Advancing to the Next Frontier of Medical Innovation:
Moving Beyond Price
Miles D. White
Chairman and CEO, Abbott Laboratories
Introduction by Kenneth Ouriel, M.D.
Chairman, Department of Vascular Surgery, The Cleveland
Clinic Foundation |
| 6:30 – 7:00 P.M. |
Buses Depart for Dinner Reception at Rock
& Roll Hall of Fame |
| 7:00 - 11:00 P.M. |
Rock This Town: Dinner Reception at the
Rock & Roll Hall of Fame Live Music
Return transportation will begin at 8:30 pm |
Wednesday, October 8, 2003
| 6:30 – 7:30 A.M. |
Continental Breakfast |
| 7:30 – 8:30 A.M. |
Medical Innovation In Action:
Live Cardiac Valvuloplasty Surgery
(interactive video broadcast live from the operating room)
Delos M. Cosgrove, M.D.
Chairman, Department of Thoracic & Cardiovascular Surgery
The Cleveland Clinic Foundation |
| 8:30 – 9:15 A.M. |
Innovation: A Pillar of Operational Excellence
Harry M. Kraemer, Jr.
Chairman and CEO, Baxter
Introduction by Martin J. Schreiber, Jr., M.D.
Board of Governors, The Cleveland Clinic Foundation |
| 9:15 – 10:00 A.M. |
Responding to the World’s Increasing Demand
for Biomedical Innovation
John W. Brown
Chairman and CEO, Stryker Corporation
Introduction by Peter R. Cavanagh, Ph.D.
Chairman, Department of Biomedical Engineering, The Cleveland
Clinic Foundation |
| 10:00 – 10:20 A.M. |
Break |
| 10:20 – 11:30 A.M. |
Increasing the Sense of Urgency
Moderator:
Delos M. Cosgrove, M.D.
Chairman, Department of Thoracic & Cardiovascular Surgery
The Cleveland Clinic Foundation
Panel:
Thomas J. Fogarty, M.D.
Co-founder and Senior Partner, Three Arch Partners
Jack W. Lasersohn
General Partner, The Vertical Group
Edward J. Ludwig
Chairman, President and CEO, BD |
| 11:30 – 12:15 P.M. |
Coming Together as an Industry in the Battle
Against
New Infectious Diseases and Bio-terrorism
Les C. Vinney
President and CEO, STERIS
Introduction by Steven M. Gordon, M.D.
Department of Infectious Diseases, The Cleveland Clinic
Foundation |
| 12:15 – 2:00 P.M. |
Luncheon
The Future of Biomedical Innovation
William C. Weldon
Chairman and CEO, Johnson & Johnson
Introduction by Jeffrey L. Ponsky, M.D.
Vice Chairman, Division of Education
Director of Graduate Medical Education and Department of
General Surgery, The Cleveland Clinic Foundation |
| 2:00 – 3:15 P.M. |
Personalized Medicine Promises to be Safer and
More Effective…
but Raises Difficult Economic and Ethical Questions
Moderator:
Eric J. Topol, M.D.
Provost and Chief Academic Officer, The Cleveland Clinic
Foundation
Panel:
C. Martin Harris, M.D.
Chief Information Officer, The Cleveland Clinic Foundation
Caroline A. Kovac, Ph.D.
General Manager, IBM Life Sciences
Raymond P. Warrell, Jr., M.D.
Chairman and CEO, Genta |
| 3:15 – 3:35 P.M. |
Break |
| 3:35 – 4:30 P.M. |
Innovation Also Requires Changes in the Healthcare
Delivery System Ron Winslow
Health Editor, Wall Street Journal
Introduction by Frank L. Lordeman
Chief Operating Officer, The Cleveland Clinic Foundation |
| 4:30 – 6:00 P.M. |
Cocktails and Convergence |
| 6:00 – 8:30 P.M. |
Dinner
Medicare Policy and New Technology
Thomas A. Scully
Administrator, Centers for Medicare & Medicaid Services,
U.S. Department of Health and Human Services
Introduction by Floyd D. Loop, M.D.
CEO, The Cleveland Clinic Foundation |
Thursday, October 9, 2003
| 7:00 – 8:00 A.M. |
Continental Breakfast |
| 8:00 – 9:00 A.M. |
Convergence with a Purpose:
Meet, Connect, Dialog, Unite, Act
Erich R. Reinhardt, D.Eng.
President and CEO, Siemens Medical Solutions
Introduction by Michael T. Modic, M.D.
Chairman, Division of Radiology, The Cleveland Clinic Foundation |
| 9:00 – 10:30 A.M. |
The Role Of Venture Capital In Improving America’s
Health
Moderator:
Keith M. Kerman, M.D.
Managing Director, Primus Venture Partners
Panel:
Samuel D. Colella
Co-founder and Managing Director, Versant Ventures
Brian H. Dovey
General Partner, Domain Associates
Bill R. Sanford
Executive Founder and Retired Chairman and CEO, STERIS;
Chairman, BioEnterprise
Harry T. Rein
Senior Advisor, Foundation Medical Partners |
| 10:30 – 11:00 A.M. |
Break |
| 11:00 – 12:00 P.M. |
Innovation to Commercialization
Panel:
Jouko Karvinen
President and CEO, Philips Medical Systems
Carl F. Kohrt, Ph.D.
President and CEO, Battelle
Introductions by Paul E. DiCorleto, Ph.D.
Chairman, Lerner Research Institute, The Cleveland Clinic
Foundation |
| 12:00 – 12:30 P.M. |
Conference Summary
The Perspectives of an Industry Statesman
George N. Hatsopoulos, Ph.D.
Chairman, Founder and CEO, Pharos;
Founder and CEO Emeritus, Thermo Electron
Introduction by Christopher M. Coburn
Executive Director, CCF Innovations
The Cleveland Clinic Foundation |
| 12:30 P.M. |
Conference Closing
Joseph F. Hahn, M.D.
Chairman, CCF Innovations
Chairman, Division of Surgery, The Cleveland Clinic Foundation |
|
|
|
